Antiangiogenic therapy and p53
Browder, T.; Folkman, J.; Hahnfeldt, P.; Heymach, J.; Hlatky, L.; Kieran, M.; Rogers, M.S.
Science 297(5581): 471; discussion 471
2002
ISSN/ISBN: 0036-8075 PMID: 12143876 Document Number: 551990
Document emailed within 1 workday
Related Documents
Tzerkovsky, D.A.; Osharin, V.V.; Istomin, Y.P.; Alexandrova, E.N.; Vozmitel, M.A. 2014: Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models Experimental Oncology 36(2): 85-89Davidson, G.S. 2005: Compounding antiangiogenic cancer therapy for animals International Journal of Pharmaceutical Compounding 9(3): 195-198
Rose, S.D.; Aghi, M.K. 2010: Mechanisms of evasion to antiangiogenic therapy in glioblastoma Clinical Neurosurgery 57: 123-128
Wu, X.Z. 2008: New strategy of antiangiogenic therapy for hepatocellular carcinoma Neoplasma 55(6): 472-481
Mamikonian, V.R.; Voevodina, T.M.; Fedorov, A.A.; Budzinskaia, M.V.; Balaian, M.L. 2013: Experimental and morphological study of the effect of antiangiogenic therapy on corneal neovessels Vestnik Oftalmologii 129(6): 45-50
Gennari, L.; Belinsky, J.; Graziano, C.; Jankilevich, G. 2011: Hypertension as predictive factor in renal cell cancer treated with antiangiogenic therapy Medicina 71(3): 207-210
Schultheis, B.; Kummer, G.; Tannapfel, A.; Strumberg, D. 2010: Successful sequential antiangiogenic therapy for alveolar soft part sarcoma - a case report International Journal of Clinical Pharmacology and Therapeutics 48(7): 468-469
Saijo, N. 2010: Treatment with antiangiogenic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 68(6): 1007-1013
Li, V.W.; Li, W.W.; Talcott, K.E.; Zhai, A.W. 2005: Imiquimod as an antiangiogenic agent Journal of Drugs in Dermatology: Jdd 4(6): 708-717
Ren, B.; Höti, N.; Rabasseda, X.; Wang, Y-Z.; Wu, M. 2003: The antiangiogenic and therapeutic implications of endostatin Methods and Findings in Experimental and Clinical Pharmacology 25(3): 215-224
Vukanovic, J.; Passaniti, A.; Hirata, T.; Traystman, R.J.; Hartley-Asp, B.; Isaacs, J.T. 1993: Antiangiogenic effects of the quinoline-3-carboxamide linomide Cancer Research 53(8): 1833-1837
Tomi, A. 2010: The role of antiangiogenic agents in age related macular degeneration Oftalmologia 54(4): 63-72
Roomi, M.W.; Kalinovsky, T.; Niedzwiecki, A.; Rath, M. 2009: Antiangiogenic properties of a nutrient mixture in a model of hemangioma Experimental Oncology 31(4): 214-219
Gately, S.; Kerbel, R. 2001: Antiangiogenic scheduling of lower dose cancer chemotherapy Cancer Journal 7(5): 427-436
Wartenberg, M.; Günther, J.; Hescheler, J.; Sauer, H. 1998: The embryoid body as a novel in vitro assay system for antiangiogenic agents Laboratory Investigation; a Journal of Technical Methods and Pathology 78(10): 1301-1314
Wietrzyk, J.; Boratynski, J.; Grynkiewicz, G.; Ryczynski, A.; Radzikowski, C.; Opolski, A. 2001: Antiangiogenic and antitumour effects in vivo of genistein applied alone or combined with cyclophosphamide Anticancer Research 21(6a): 3893-3896
Soltau, J.; Zirrgiebel, U.; Esser, N.; Schächtele, C.; Totzke, F.; Unger, C.; Merfort, I.; Drevs, J. 2008: Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model Anticancer Research 28(2a): 933-941
Dong, Z.-Z.; Yao, D.-F.; Wu, W.; Yao, M.; Yu, H.-B.; Shen, J.-J.; Qiu, L.-W.; Yao, N.-H.; Sai, W.-L.; Yang, J.-L. 2010: Delayed hepatocarcinogenesis through antiangiogenic intervention in the nuclear factor-kappa B activation pathway in rats Hepatobiliary and Pancreatic Diseases International: Hbpd Int 9(2): 169-174
Wilczyńska, U.; Kucharska, A.; Szary, J.; Szala, S. 2001: Combined delivery of an antiangiogenic protein (angiostatin) and an immunomodulatory gene (interleukin-12) in the treatment of murine cancer Acta Biochimica Polonica 48(4): 1077-1084
Dutour, A.; Rigaud, M. 2005: Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies Anticancer Research 25(6b): 3799-3807